載入...
Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood malignancy that arises from the clonal expansion of transformed T-cell precursors. Although T-ALL prognosis has significantly improved due to the development of intensive chemotherapeutic protocols, primary drug-resistant and relapse...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6073309/ https://ncbi.nlm.nih.gov/pubmed/29949919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19071878 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|